文献速递心脏核医学肿瘤 PET/CT

PET/CT形态学与心脏传导障碍有助于鉴别原发性心脏淋巴瘤与原发性心脏肉瘤

PET/CT morphology and cardiac conduction disorders help discriminate primary cardiac lymphoma from primary cardiac sarcoma.
PubMed 文献 · J Nucl Cardiol · 2022-07-05

本研究纳入原发性心脏淋巴瘤(PCL,n=14)与原发性心脏肉瘤(PCS,n=15)患者,比较治疗前18F-FDG PET/CT形态代谢特征及临床资料。多因素logistic回归显示R_Kurtosis(OR=27.025,P=.007)和心脏传导障碍(OR=37.732,P=.016)为PCL的独立预测因素,分类回归树将患者分为三个亚组,PCL概率分别为88.9%、80.0%和13.3%。

要点

  • PCL较PCS发病年龄更大,心功能障碍与心律失常更多,糖代谢更高。
  • R_Kurtosis(OR=27.025,P=.007)和心脏传导障碍(OR=37.732,P=.016)为PCL独立预测因素。
  • R_Kurtosis≥0.044组PCL概率88.9%,<0.044伴传导障碍组80.0%,<0.044不伴传导障碍组13.3%。

核心结论

  • PET衍生的肿瘤膨胀模式(R_Kurtosis)和心脏传导障碍有助于鉴别PCL与PCS,可能辅助临床管理。

研究设计与样本

  • 回顾性纳入PCL患者14例和PCS患者15例,分析治疗前18F-FDG PET/CT与增强CT的形态代谢特征及临床资料。

主要发现

  • 与PCS相比,PCL发病年龄更大,心功能障碍和心律失常更多,糖代谢更高(SUVmax、SUVpeak、SUVmean、MTV、TLG均更高)。
  • 根治性治疗改善PCL生存而未改善PCS生存。
  • 多因素logistic回归显示R_Kurtosis(OR=27.025,P=.007)和心脏传导障碍(OR=37.732,P=.016)为PCL的独立预测因素。
  • 分类回归树分析将患者分为三个亚组:R_Kurtosis≥0.044组PCL概率88.9%,R_Kurtosis<0.044伴传导障碍组80.0%,R_Kurtosis<0.044不伴传导障碍组13.3%。

关键数值与推荐

  • R_Kurtosis≥0.044时PCL概率为88.9%。
  • R_Kurtosis<0.044且伴心脏传导障碍时PCL概率为80.0%。
  • R_Kurtosis<0.044且不伴心脏传导障碍时PCL概率为13.3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary cardiac lymphoma (PCL) and primary cardiac sarcoma (PCS) are similar in clinical presentation but differ in management and outcomes. We aim to explore the role of PET morphology and clinical characteristics in distinguishing PCL from PCS. METHODS: Pretreatment 18F-FDG PET/CT and contrast-enhanced CT were performed in PCL (n = 14) and PCS (n = 15) patients. Patient demographics, overall survival, and progression-free survival were reviewed. PET/CT morphological and metabolic features were extracted. Specifically, R_Kurtosis, a PET-morphology parameter reflecting the tumor expansion within the heart, was calculated. RESULTS: Compared with PCS, PCL occurred at an older age, resulted in more cardiac dysfunctions and arrhythmias, and showed higher glucometabolism (SUVmax, SUVpeak, SUVmean, MTV, and TLG). Curative treatments improved survival for PCL but not for PCS. Multivariable logistic regression identified R_Kurtosis (OR = 27.025, P = .007) and cardiac conduction disorders (OR = 37.732, P = .016) independently predictive of PCL, and classification and regression tree analysis stratified patients into three subgroups: R_Kurtosis ≥ 0.044 (probability of PCL 88.9%), R_Kurtosis < 0.044 with conduction disorders (80.0%), and R_Kurtosis < 0.044 without conduction disorders (13.3%). CONCLUSION: PET-derived tumor expansion pattern (R_Kurtosis) and cardiac conduction disorders were helpful in distinguishing PCL from PCS, which might assist the clinical management.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Yuan H, Qiu J, Chiu KWH, et al. PET/CT morphology and cardiac conduction disorders help discriminate primary cardiac lymphoma from primary cardiac sarcoma. J Nucl Cardiol. 2022. PMID: 35790691. doi:10.1007/s12350-022-03042-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。